New breast cancer study: Results of the TARGIT-A clinical trial
A new clinical trial for breast cancer, published in The Lancet, shows that a single fraction of targeted intraoperative radiotherapy (TARGIT) delivered with the ZEISS INTRABEAM® at time of lumpectomy is non-inferior to traditional external beam radiation (EBRT) delivered over three to six weeks after breast conserving surgery, for a select group of patients."The most important benefit of TARGIT for a woman with breast cancer is that it allows her to complete her entire local treatment at the time of her operation, with lower toxicity to the breast, the heart and other organs. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 3, 2013 Category: Consumer Health News Tags: Breast Cancer Source Type: news
Radiation at Surgery Equal to Whole-Breast RT (CME/CE)
(MedPage Today) -- Intraoperative radiation therapy (IORT) for early breast cancer demonstrated noninferiority to whole-breast external beam radiation therapy (EBRT) in two randomized clinical trials. (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - November 11, 2013 Category: Hematology Source Type: news
"One-stop" radiotherapy could offer an alternative to lengthy and inconvenient post-surgery procedures for breast cancer
Two new studies, published in The Lancet and The Lancet Oncology, show that targeted radiotherapy delivered during surgery could offer a viable alternative to current procedures - which require women to attend daily radiotherapy sessions for weeks after surgery - for some women undergoing surgery for early breast cancer. Most women who undergo partial mastectomy (lumpectomy) surgery for breast cancer also complete a course of radiotherapy delivered to the whole of the affected breast (called external beam radiotherapy, EBRT)... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 11, 2013 Category: Consumer Health News Tags: Breast Cancer Source Type: news
Mortality risks not increased by external beam RT in early-stage breast cancer
Early-stage breast cancer patients who receive external beam therapy (XRT) are not at higher risk for serious long-term side effects in the chest area, including increase in deaths from cardiac disease and secondary malignancies, according to research presented at the American Society for Radiation Oncology's (ASTRO's) 55th Annual Meeting. The study utilized patient information from the National Cancer Institute's Surveillance, Epidemiology and End Results (SEER) database... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - September 26, 2013 Category: Consumer Health News Tags: Breast Cancer Source Type: news
External beam RT for early-stage breast cancer does not increase mortality risks
(American Society for Radiation Oncology) Early-stage breast cancer patients who receive external beam therapy are not at higher risk for serious long-term side effects in the chest area, including increase in deaths from cardiac disease and secondary malignancies, according to research presented today at the American Society for Radiation Oncology's 55th Annual Meeting. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 24, 2013 Category: Global & Universal Source Type: news
Chemoradiation Therapy for the Treatment of Bone Metastases
The combination of the chemotherapy capecitabine with external beam radiation was found to be both safe and effective in treating pain from bone metastases in patients with advanced breast cancer. (Source: Cancer Network)
Source: Cancer Network - August 2, 2013 Category: Cancer & Oncology Source Type: news
Mortality After Radical Prostatectomy for Prostate CancerMortality After Radical Prostatectomy for Prostate Cancer
For localized prostate cancer, which treatment has better outcomes, radical prostatectomy or external beam radiotherapy? Journal of the National Cancer Institute (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 20, 2013 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news
Improved Radionuclide Drug Treatment Planning With 3D Patient Models And Quantification Of Therapeutic Dose
External beam radiation treatment has long been manipulated into the unique shape of patients' tumors for personalized cancer care. Technology providing a means of patient-specific radionuclide drug therapies has not been standardized, as it has been limited to software that requires oncologists to manually define the areas of tumors... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - June 13, 2013 Category: Consumer Health News Tags: Radiology / Nuclear Medicine Source Type: news
External Beam Radiation Therapy for Prostate...
Radiation therapy is a commonly-used treatment for prostate cancer. Radiation therapy can be administered from outside the body (external beam radiation therapy) or from inside the body (brachytherapy). (Source: About.com Prostate Cancer)
Source: About.com Prostate Cancer - June 5, 2013 Category: Cancer & Oncology Tags: health Source Type: news
Side Effects of External Beam Radiation Therapy...
It is important to understand the potential side effects that may result from external beam radiation therapy (EBRT) for prostate cancer. (Source: About.com Prostate Cancer)
Source: About.com Prostate Cancer - June 5, 2013 Category: Cancer & Oncology Tags: health Source Type: news
Definition of EBRT (External Beam Radiation...
EBRT - Definition of EBRT (external beam radiation therapy). Learn the meaning of EBRT for prostate cancer. (Source: About.com Prostate Cancer)
Source: About.com Prostate Cancer - June 5, 2013 Category: Cancer & Oncology Tags: health Source Type: news
Yes, nanoscience can enhance humans – but ethical guidelines must be agreed
People 'enhanced' into spider-climbing individuals with hugely projected breasts and Einstein-brains… Where will it stop?Engineers are trained to try to figure out how to achieve things that humans cannot and in nanoscience and nanotechnology that challenge is no different.Many of the most exciting advances in the field try to improve human incapacities with things such as memory, hearing, stamina or intellect. In my field of nanomedicine, the notion of human enhancement is, in a lot of cases, a way to deal with disease: enhancing vision, cognitive functions or improving a person's ability to move independently.I have al...
Source: Guardian Unlimited Science - June 3, 2013 Category: Science Authors: Kostas Kostarelos Tags: Blogposts Biology guardian.co.uk Medical research Nanotechnology Human biology Science Source Type: news
New risk classification system proposed for prostate cancer
US researchers have put forward a risk stratification system for patients with intermediate-risk prostate cancer undergoing dose-escalated external-beam radiation therapy. (Source: MedWire News - Oncology)
Source: MedWire News - Oncology - April 29, 2013 Category: Cancer & Oncology Source Type: news
New risk classification system proposed for prostate cancer
US researchers have put forward a risk stratification system for patients with intermediate-risk prostate cancer undergoing dose-escalated external-beam radiation therapy. (Source: MedWire News - Urology)
Source: MedWire News - Urology - April 29, 2013 Category: Urology & Nephrology Source Type: news
Brachytherapy Boost an Option for Base-of-Tongue CancerBrachytherapy Boost an Option for Base-of-Tongue Cancer
A high-dose-rate interstitial brachytherapy boost after external-beam radiotherapy is associated with 'acceptable' local control and overall survival in base-of-tongue cancer, new research shows. Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 24, 2013 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
